Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-1-28
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0001-5555
pubmed:author
pubmed:issnType
Print
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
91-2
pubmed:meshHeading
pubmed-meshheading:20107738-Adult, pubmed-meshheading:20107738-DNA Mutational Analysis, pubmed-meshheading:20107738-Drug Therapy, Combination, pubmed-meshheading:20107738-Female, pubmed-meshheading:20107738-Fibrinolytic Agents, pubmed-meshheading:20107738-Genetic Predisposition to Disease, pubmed-meshheading:20107738-Heterozygote, pubmed-meshheading:20107738-Homozygote, pubmed-meshheading:20107738-Humans, pubmed-meshheading:20107738-Hyperbaric Oxygenation, pubmed-meshheading:20107738-Livedo Reticularis, pubmed-meshheading:20107738-Mutation, pubmed-meshheading:20107738-Plasminogen Activator Inhibitor 1, pubmed-meshheading:20107738-Promoter Regions, Genetic, pubmed-meshheading:20107738-Prothrombin, pubmed-meshheading:20107738-Skin, pubmed-meshheading:20107738-Tissue Plasminogen Activator, pubmed-meshheading:20107738-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.
pubmed:publicationType
Letter, Case Reports